Showing results (61-70 of 326) with videos related to

Sort By:
Pageof 33
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|September 30, 2006
Atrophy-related ubiquitin ligases atrogin-1 and MuRF-1 are associated with uterine smooth muscle involution in the postpartum periodYuval Bdolah, Adam Segal, Preeti Tanksale, et al.
Molecular and Cellular Biology|February 19, 2009
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endotheliumHai Tao Yuan, Eliyahu V Khankin, S Ananth Karumanchi, et al.
Seminars in Nephrology|December 15, 2010
Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarkerEmily S Robinson, Eliyahu V Khankin, S Ananth Karumanchi, et al.
Placenta|July 28, 2020
A mouse model of placenta accreta spectrumSuzanne D Burke, Zsuzsanna K Zsengellér, S Ananth Karumanchi, et al.
The Journal of Clinical Investigation|March 6, 2003
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaSharon E Maynard, Jiang-Yong Min, Jaime Merchan, et al.
Molecular Cancer Research : MCR|November 23, 2006
Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cellsShivalingappa Venkatesha, Jun-Ichi Hanai, Pankaj Seth, et al.
FASEB Bioadvances|September 6, 2021
Normalization of wall shear stress as a physiological mechanism for regulating maternal uterine artery expansive remodeling during pregnancyEliyahu V Khankin, Nga Ling Ko, Maurizio Mandalà, et al.
Kidney International|October 2, 2004
Regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF-A) expression in podocytesKaustubh Datta, Jinping Li, S Ananth Karumanchi, et al.
Placenta|May 31, 2016
Revisiting decidual vasculopathyJonathan L Hecht, Zsuzsanna K Zsengeller, Melissa Spiel, et al.
Cancer Causes & Control : CCC|July 1, 2016
A prospective study of angiogenic markers and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trialRoni T Falk, Annetine Cathrine Staff, Gary Bradwin, et al.
Pageof 33